← Leaderboards
David W Russell
University Of Washington
$27,160,623
Attributed
$28,075,932
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$28,075,932 · 12
By mechanism
R01$17,223,241 · 6
T32$5,499,429 · 1
P01$3,804,262 · 2
U01$1,539,000 · 2
R13$10,000 · 1
Top collaborators
- Markus Grompe3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Gregory Findlay$130,402
- Peter H. Byers$1,792,915
- David R Deyle$2,826,042
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingCellsVectorGenesGene TherapyBaseTransplantationHereditary DiseaseResearch StudyMutationSiteDependovirusStem CellsCell TypeDesignGenotoxicityAdeno-Associated Viral VectorLeadFundingAnimal ModelGrantCd34 GeneInduced Pluripotent Stem CellMaps
Grant awards (74)
Liver Cancer Risk with rAAV Gene Therapy$585,925
R01 · FY2017 · CA
AAV-Mediated Gene Targeting$336,038
R01 · FY2017 · DK · contact PI
Liver Cancer Risk with rAAV Gene Therapy$636,568
R01 · FY2016 · CA
Universal Donor Megakaryocytes$398,818
R01 · FY2016 · HL · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$373,437
R01 · FY2016 · HL · contact PI
AAV-Mediated Gene Targeting$336,038
R01 · FY2016 · DK · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$695,443
R01 · FY2015 · HL · contact PI
Liver Cancer Risk with rAAV Gene Therapy$608,126
R01 · FY2015 · CA
HEMATOLOGY TRAINING$531,084
T32 · FY2015 · HL · contact PI
Universal Donor Megakaryocytes$412,413
R01 · FY2015 · HL · contact PI
AAV-Mediated Gene Targeting$336,038
R01 · FY2015 · DK · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$654,926
R01 · FY2014 · HL · contact PI
Derivation and Correction of Thalassemic Pluripotent Stem Cells$456,397
P01 · FY2014 · HL · contact PI
HEMATOLOGY TRAINING$448,008
T32 · FY2014 · HL · contact PI
AAV-Mediated Gene Targeting$336,038
R01 · FY2014 · DK · contact PI
American Society of Gene & Cell Therapy (ASGCT) 17th Annual Meeting$10,000
R13 · FY2014 · TR · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$530,649
R01 · FY2013 · HL · contact PI
HEMATOLOGY TRAINING$518,253
T32 · FY2013 · HL · contact PI
Derivation and Correction of Thalassemic Pluripotent Stem Cells$429,996
P01 · FY2013 · HL · contact PI
HEMATOLOGY TRAINING$518,253
T32 · FY2012 · HL · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$482,211
R01 · FY2012 · HL · contact PI
Derivation and Correction of Thalassemic Pluripotent Stem Cells$455,111
P01 · FY2012 · HL · contact PI
Gene Targeting and Integration by Adeno-Associated Virus Vectors$422,652
R01 · FY2012 · DK · contact PI
HEMATOLOGY TRAINING$510,762
T32 · FY2011 · HL · contact PI
Derivation and Correction of Thalassemic Pluripotent Stem Cells$453,876
P01 · FY2011 · HL · contact PI
Gene Targeting and Integration by Adeno-Associated Virus Vectors$422,687
R01 · FY2011 · DK · contact PI
Gene Targeting and Integration by Adeno-Associated Virus Vectors$31,099
R01 · FY2011 · DK · contact PI
HEMATOLOGY TRAINING$502,312
T32 · FY2010 · HL · contact PI
Gene Targeting and Integration by Adeno-Associated Virus Vectors$479,752
R01 · FY2010 · DK · contact PI
Derivation and Correction of Thalassemic Pluripotent Stem Cells$450,893
P01 · FY2010 · HL · contact PI
Gene Targeting Strategies for the Treatment of Osteogenesis Imperfecta$320,622
R01 · FY2010 · AR · contact PI
Derivation and Transplantation of Histocompatible Pluripotent Stem Cells$312,000
R01 · FY2010 · GM · contact PI
Gene Targeting and Integration by Adeno-Associated Virus Vectors$31,099
R01 · FY2010 · DK · contact PI
Research Training in Hematology$475,620
T32 · FY2009 · HL · contact PI
Gene Targeting and Integration by Adeno-Associated Virus Vectors$471,313
R01 · FY2009 · DK · contact PI
GENE TARGETING STRATEGIES FOR THE TREATMENT OF OSTEOGENESIS IMPERFECTA$428,966
R01 · FY2009 · AR · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$389,853
R01 · FY2009 · HL · contact PI
Gene Targeting Strategies for the Treatment of Osteogenesis Imperfecta$323,861
R01 · FY2009 · AR · contact PI
Derivation and Transplantation of Histocompatible Pluripotent Stem Cells$312,000
R01 · FY2009 · GM · contact PI
Research Training in Hematology$500,751
T32 · FY2008 · HL · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$364,161
R01 · FY2008 · HL · contact PI
GENE TARGETING STRATEGIES FOR THE TREATMENT OF OSTEOGENESIS IMPERFECTA$323,861
R01 · FY2008 · AR · contact PI
Gene Targeting by Adeno-Associated Virus Vectors$309,913
R01 · FY2008 · DK · contact PI
Foamy Virus Vectors for Stem Cells$286,348
P01 · FY2008 · HL · contact PI
Research Training in Hematology$492,884
T32 · FY2007 · HL · contact PI
Treatment of Leukocyte Adhesion Deficiency by Foamy Virus Vectors$354,018
R01 · FY2007 · HL · contact PI
Foamy Virus Vectors for Stem Cells$333,589
P01 · FY2007 · HL · contact PI
GENE TARGETING STRATEGIES FOR THE TREATMENT OF OSTEOGENESIS IMPERFECTA$330,470
R01 · FY2007 · AR · contact PI
Gene Targeting by Adeno-Associated Virus Vectors$316,238
R01 · FY2007 · DK · contact PI
Research Training in Hematology$500,751
T32 · FY2006 · HL · contact PI
Treatment Leukocyte Adhesion Deficiency by Foamy Virus$372,337
R01 · FY2006 · HL · contact PI
GENE TARGETING STRATEGIES FOR THE TREATMENT OF OSTEOGENESIS IMPERFECTA$353,503
R01 · FY2006 · AR · contact PI
Gene Targeting by Adeno-Associated Virus Vectors$325,682
R01 · FY2006 · DK · contact PI
Foamy Virus Vectors for Stem Cells$321,630
P01 · FY2006 · HL · contact PI
Research Training in Hematology$500,751
T32 · FY2005 · HL
Collagen Gene Targeting with AAV Vectors$379,000
R01 · FY2005 · AR
Gene Targeting by Adeno-Associated Virus Vectors$333,520
R01 · FY2005 · DK
Foamy Virus Vectors for Stem Cells$312,766
P01 · FY2005 · HL
Collagen Gene Targeting with AAV Vectors$379,000
R01 · FY2004 · AR
Foamy Virus Vectors for Stem Cells$303,656
P01 · FY2004 · HL
GENE TARGETING BY VIRAL VECTORS$270,188
R01 · FY2004 · DK
Collagen Gene Targeting with AAV Vectors$379,000
R01 · FY2003 · AR
GENE TARGETING BY VIRAL VECTORS$262,319
R01 · FY2003 · DK
Collagen Gene Targeting with AAV Vectors$379,000
R01 · FY2002 · AR
GENE THERAPY TRAINING$256,500
U01 · FY2002 · HL
GENE TARGETING APPROACH FOR BLOOD DISEASES$256,500
U01 · FY2002 · HL
GENE TARGETING BY VIRAL VECTORS$254,678
R01 · FY2002 · DK
Collagen Gene Targeting with AAV Vectors$379,833
R01 · FY2001 · AR
GENE THERAPY TRAINING$256,500
U01 · FY2001 · HL
GENE TARGETING APPROACH FOR BLOOD DISEASES$256,500
U01 · FY2001 · HL
GENE TARGETING BY VIRAL VECTORS$247,261
R01 · FY2001 · DK
GENE THERAPY TRAINING$256,500
U01 · FY2000 · HL
GENE TARGETING APPROACH FOR BLOOD DISEASES$256,500
U01 · FY2000 · HL
GENE TARGETING BY VIRAL VECTORS$240,687
R01 · FY2000 · DK